Live Breaking News & Updates on Prefers This Stock Over
Stay updated with breaking news from Prefers this stock over. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Recursion reported fourth-quarter revenue of $10.89 million, which missed the consensus estimate of $20.35 million. The clinical stage biotech company reported a quarterly loss of 42 cents per share, which beat estimates for a loss of 44 cents per share, according to Benzinga Pro ....